Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04226586 · ClinicalTrials.gov registry record · NA
Nutritional Stimulation of Growth in Children With Short Stature
A NA study of Growth Failure and Nutritional Stunting, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT04226586: Completed NA study of Growth Failure and Nutritional Stunting, sponsored by Arkansas Children's Hospital Research Institute.
NCT04226586 is a NA study of Growth Failure and Nutritional Stunting that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 24 participants, below the 155-participant average among 4 other Growth Failure trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04226586, a NA study of Growth Failure and Nutritional Stunting, has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Short stature is a frequent reason for referral to a pediatric endocrinology clinic. Short stature is especially prevalent among those with failure to thrive (whose weight is significantly below the average weight of his/her peers). The growth hormone has limited efficacy for medical treatment of short stature when the cause of short stature is not growth hormone deficiency. This study will investigate the effect of 6 months of nutritional supplement (essential amino acids) compared to placebo in the linear growth of short children who have not yet reached puberty.
Primary Outcome
Growth velocity (cm/year) will be calculated and compared between arms using the height measurements taken before and after 6 months of Essential Amino Acids vs Placebo supplementation.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Essential Amino Acid (EAA) group
Study Locations (1)
Arkansas
- Emir Tas - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT04226586 record still lists
NCT04226586 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 155-participant average among 4 other Growth Failure trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Growth Failure appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04226586 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT04226586 about?
NCT04226586 is a clinical study titled "Nutritional Stimulation of Growth in Children With Short Stature". Short stature is a frequent reason for referral to a pediatric endocrinology clinic. Short stature is especially prevalent among those with failure to thrive (whose weight is significantly below the average weight of his/her peers). The growth hormone has limited efficacy for medical treatment of sh...
What is the current status of trial NCT04226586?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2020-09-09. Estimated completion is 2022-12-31.
What conditions does trial NCT04226586 study?
This clinical trial studies the following conditions: Growth Failure, Nutritional Stunting.
What interventions are being tested in trial NCT04226586?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Essential Amino Acid (EAA) group (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04226586?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04226586 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Growth Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Targeted Fortification of Donor Breast Milk in Preterm Infants
RECRUITING · NA
-
Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk
ACTIVE NOT RECRUITING · NA
-
A Cohort Study of the Intestinal Microbiota of Premature Infants
ACTIVE NOT RECRUITING
-
Is There a Microbiome Associated With Poor Growth in Preterm Infants?
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI